President Donald Trump’s administration is looking “very strongly” at reclassifying cannabis from the strictest category of controlled substances, Trump said Monday.

In a brief affirmative response to a reporter’s question in the Oval Office, the president confirmed he is considering a reclassification of marijuana to unlock research funding.

“A lot of people want to see it — the reclassification — because it leads to tremendous amounts of research that can’t be done unless you reclassify,” Trump said. “So we are looking at that very strongly.”

Marijuana is considered a Schedule I drug under the Food and Drug Administration’s classification of controlled substances. The FDA defines drugs on the list, such as heroin and cocaine, as lacking any medicinal value and carrying a high likelihood of abuse.

The designation carries a host of consequences, including a virtual ban on funding research for medicinal or other uses of the drug.

While marijuana use, both medicinal and recreational, is legal in many states, it remains illegal to possess or use in any amount for any reason under federal law.

Advocates have sought for decades to legalize or decriminalize the drug, which many see as less harmful than other Schedule I substances.

The growing split in recent years among many states and federal law has ramped up pressure on federal policymakers to alter the drug’s legal status.

Marijuana businesses in states where it is legal lack access to financial institutions, which cannot lend to businesses considered illegal by federal authorities.

States, meanwhile, have had difficulty regulating the environmental and health aspects of their industries.

And lawmakers, especially Democrats, have increasingly highlighted the frequent injustice of marijuana prosecutions that disproportionately affect communities of color and poor communities, though the drug is widely used across race and economic status.